Baillie Gifford & Co’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-63,333
| Closed | -$688K | – | 293 |
|
|
2024
Q2 | $688K | Sell |
63,333
-17,483
| -22% | -$190K | ﹤0.01% | 261 |
|
|
2024
Q1 | $1.51M | Sell |
80,816
-3,949
| -5% | -$74K | ﹤0.01% | 251 |
|
|
2023
Q4 | $1.84M | Sell |
84,765
-3,742
| -4% | -$81.1K | ﹤0.01% | 254 |
|
|
2023
Q3 | $1.82M | Sell |
88,507
-5,212
| -6% | -$107K | ﹤0.01% | 255 |
|
|
2023
Q2 | $4.41M | Sell |
93,719
-1,326
| -1% | -$62.3K | ﹤0.01% | 244 |
|
|
2023
Q1 | $3.99M | Buy |
95,045
+160
| +0.2% | +$6.71K | ﹤0.01% | 245 |
|
|
2022
Q4 | $3.62M | Buy |
94,885
+3,490
| +4% | +$133K | ﹤0.01% | 250 |
|
|
2022
Q3 | $3.58M | Buy |
91,395
+2,949
| +3% | +$116K | ﹤0.01% | 253 |
|
|
2022
Q2 | $2.86M | Sell |
88,446
-10,320
| -10% | -$333K | ﹤0.01% | 257 |
|
|
2022
Q1 | $3.27M | Buy |
98,766
+8,394
| +9% | +$278K | ﹤0.01% | 261 |
|
|
2021
Q4 | $3.85M | Buy |
90,372
+4,074
| +5% | +$173K | ﹤0.01% | 261 |
|
|
2021
Q3 | $3.82M | Buy |
86,298
+6,033
| +8% | +$267K | ﹤0.01% | 262 |
|
|
2021
Q2 | $4.56M | Buy |
80,265
+10,516
| +15% | +$597K | ﹤0.01% | 259 |
|
|
2021
Q1 | $5.22M | Buy |
69,749
+36,833
| +112% | +$2.76M | ﹤0.01% | 252 |
|
|
2020
Q4 | $2.85M | Buy |
32,916
+15,886
| +93% | +$1.37M | ﹤0.01% | 240 |
|
|
2020
Q3 | $1.04M | Buy |
17,030
+15,440
| +971% | +$944K | ﹤0.01% | 239 |
|
|
2020
Q2 | $66K | Buy |
1,590
+711
| +81% | +$29.5K | ﹤0.01% | 241 |
|
|
2020
Q1 | $25K | Buy |
879
+389
| +79% | +$11.1K | ﹤0.01% | 224 |
|
|
2019
Q4 | $35K | Hold |
490
| – | – | ﹤0.01% | 225 |
|
|
2019
Q3 | $69K | Buy |
+490
| New | +$69K | ﹤0.01% | 221 |
|